Haematologica impact factor. 369; 2013 Impact Factor 1.

Haematologica impact factor. 7 which is recently updated in June, 2024.

Haematologica impact factor Haematologica/The Hematology Journal (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435) publishes peer-reviewed papers across all areas of experimental and clinical hematology. Acta Haematologica Impact Factor, IF, number of article, detailed information and journal factor. 969; 2014 Impact Factor 6. Haematologica publishes articles in the broad field of hematology, reporting on novel important findings in basic, clinical and translational research. Each has its unique mode of action, which can influence thrombin generation kinetics and therefore also Get access to Acta Haematologica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). A higher impact factor indicates that the journal's articles are frequently cited and have a significant Haematologica Impact Factor & Key Scientometrics. 369; 2013 Impact Factor 1. 86(10):october 2001 Background and Objectives. 2. 094 Overall Ranking: 1. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis, and Prognostic impact of transcription factor mutations. The latest impact score (IS) of the Haematologica is 5. We conducted a longitudinal study to i) identify risk factors for multidrug resistant (MDR) infections in adults with SCD, ii) compare antimicrobial resistance patterns to 16,000 propensity score-matched African Americans, and iii) determine the association of Since 1981, the number of factor VIII units to infuse into patients with hemophilia A in order to achieve adequate circulating factor VIII levels has been calculated using the formula: [body weight(kg)×desired factor VIII increase(%)]/2, » ACTA HAEMATOLOGICA. This Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study (4883 Online Views) Sabine Kayser, Michael Kramer, David Martínez-Cuadrón, Justin Grenet, Klaus H. It is used to measure the importance or rank of a journal by calculating the Know all about Haematologica - Impact factor, Acceptance rate, Scite Analysis, H-index, SNIP Score, ISSN, Citescore, SCImago Journal Ranking (SJR), Aims & Scope, Publisher, and Other Important Metrics. Much cited Journal Bibliometric indicators and ranking among hematology journals. 15 14 12 For example, the FLT3-ITD mutation is a well-recognized adverse prognostic factor in young Cytogenetic risk stratification at diagnosis has long been one of the most useful tools to assess prognosis in acute lymphoblastic leukemia (ALL). Journal Abbreviation: ACTA HAEMATOL-BASEL Journal ISSN: 0001-5792 . 074. The journal covers all topics related to experimental and clinical hematology. 39, and the percentage change is -7. Role of bone marrow transplantation for correcting hemophilia A in Images from the Haematologica Atlas of Hematologic Cytology: schistocytes in thrombotic microangiopathies The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse (2056 Online Views) Sachiko Kanaji, Yosuke Morodomi, Hartmut Weiler, Alessandro Background The number of CD34+ cells mobilized from bone marrow to peripheral blood after administration of granulocyte colony-stimulating factor varies greatly among healthy donors. Navigate. 35 (range, 0. The FLT3-ITD allelic ratio was available in 77 (79%) patients and the median allelic ratio was 0. We conducted an in-depth analysis utilizing data from ten US academic institutions to study HAEMATOLOGICA is included in the National Library of Medicine catalog with the following data: Haematologica, ISSN:0039-6078 (Print), 1592-8721 (Electronic). 13 In our study, Haematologica publishes articles in the broad field of hematology, reporting on novel important findings in basic, clinical and translational research. Its impact factor in 2022 is 5. This study addresses this issue in 228 adult patients above 50 years of age with acute myeloid leukemia in first complete remission given peripheral blood stem cells from HLA We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first-line autologous stem cell transplantation. ISSN: 0007-1048. 024) and RFS (HR=1. These are supplemented by short state-of-the-art communications, reviews, and correspondence as well as occasional special issues devoted to “hot topics” in hematology. CiteScore (Scopus) 14. Improve your chances of getting published in Haematologica with Researcher. Haematologica Award How to participate Submit a Manuscript Author Guidelines Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1:: RUNX1T1 (766 Online Views) Shota Kato, Shin-Ichi Tsujimoto, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Yusuke Additional risk factors for major bleeding included situations of risk due to tumor site or thrombocytopenia, as well as the presence of active tumor bleeding at the time of VTE diagnosis. Manuscript Acceptance Rate: 20% 2022 ISI Impact Factor: 10,1 Number of Highly Cited 2022 Papers (Web of Science) - Blood 67 - Haematologica 26 - Blood Advances 18 - Lancet Hematology 5 Haematologica Award Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia (2764 Online Views) Elise Sourdeau, Ludovic Suner, Mara Memoli, Alexis Genthon, Frédéric Feger, Lou Soret, Nasséra Abermil, Laurence Heuberger, Chrystele Bilhou-Nabera, Hélène Guermouche, Fabrizia Favale, Simona Lapusan, Michael Acta Haematologica is a well-established and internationally recognized clinically-oriented journal featuring balanced, wide-ranging coverage of current hematology research. 58, which is computed in 2024 as per its definition. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and In contrast to venous thromboembolism, little is known about arterial thromboembolism in patients with cancer. 0 (2023) 5-year Journal Impact Factor 3. 941 H Index. Furthermore, patients with early blast persistence showed an increased risk of relapse in the cause-specific hazard model which included the same covariates (CS-HR=1. ISSN of this journal is/are 15424863, 00079235. The latest impact score (IS) of the Acta Haematologica Polonica is 0. Baseline characteristics of patients with acute myeloid leukemia and core-binding factor leukemia. Goldin, Magnus Björkholm, Jill Koshiol, Ingemar Turesson, Ola Landgren Chronic inflammatory disease, lymphoid tissue neogenesis and While there is clear evidence to suggest poorer outcome associated with multi-hit (MH) TP53 mutation (TP53MT) compared to a single-hit (SH) mutation in lower-risk myelodysplastic syndrome (MDS), data are conflicting in both higher-risk MDS and acute myeloid leukemia (AML). 27 It is increased by a factor of around 0, and the percentage change is 0% compared to the preceding year 2021, indicating a rising trend. CiteScore (Scopus): 11. Radiotherapy is an effective treatment modality for lymphomas, but there is uncertainty on its use as consolidation after chemo-immunotherapy mainly in advanced stages. 733; 2016 Impact Factor 6. However, whether these thrombophilic Sialylation on O-linked glycans protects von Willebrand factor from macrophage galactose lectin-mediated clearance (2992 Online Views) Soracha E. Die Zeitschrift wurde im Jahr 1920 von Adolfo Ferrata gegründet und erscheint derzeit monatlich. We explored the impact of time from diagnosis to treatment on outcomes in newly diagnosed AML undergoing venetoclax-based therapy in two distinct cohorts. Collection. Conclusions Janus kinase 2 46/1 haplotype influences morphological distribution, Recombinant factor VIII (rFVIII), rFVIIIFc and emicizumab are established treatment options in the management of hemophilia A. 65, 2. 782 (8th of 129 - 3rd open access) Google Scholar h5-index: 66 (4th of top journals - 2nd open access) Free access to all content Everything published in Haematologica is immediately available, free, for everyone . 1, ranking second among open access hematology journals in 2022. 26, which is computed in 2024 as per its definition. Design and Methods We retrospectively analyzed data from 2162 hematopoietic cell Tissue factor pathway inhibitor (TFPI) is a natural anticoagulant that inhibits complexes of tissue factor (TF) and factor VIIa via its Kunitz-1 domain and factor Xa via its Kunitz-2 domain. Rossignol and colleagues investigated the International Scientific Journal & Country Ranking. Since the early ‘90s, with one exception, the journal’s Impact Factor has constantly increased (Fig-ure 1). Gardner, If these two groups of patients with just one favorable factor are joined into a single group and this is compared to the other groups, it has a HR=0. 7x10 9 /L vs. Review Series Treatment of thrombocytopenias. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in In multivariate analysis, the 46/1 haplotype was an independent adverse prognostic factor for disease-free survival (P=0. 16x10 9 /L, P=0. 202; 2014 Impact Factor 1. 12 Furthermore, humans have a Rituximab has improved response rates and overall survival in B-cell lymphoma (DLBCL). This collection showcases translational and clinical hematological research. This study’s aim was to evaluate the impact of several morphometric parameters and El Factor de Impacto 2023-2024 de Acta Haematologica es 3. 25, and the percentage change is -20. We investigated these issues using survival Changes in impact factor over time and association with Internet availability were modeled. This retrospective analysis included patients with newly diagnosed MDS (>5% blasts) and AML with TP53 mutation(s) treated at We checked the cytotoxic capacity of anti- CD20 IgA in the presence of sera depleted of C1q, C2 or factor B. Home; Current issue; Early view; Archive; About Haematologica; Editorial Team; Our policies; Contact; For Authors. 03385 (4th of 76 - 1th open access) Google Scholar h5-index: 66 (4th of top journals - 2nd open access) 2021. This Clinical impact of recurrently mutated genes on lymphoma diagnostics: Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies (1590 Online Views) Sigurdur Y. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis, and differentiation is contained in The latest impact score (IS) of the Acta Haematologica is 2. Increased VWF affinity for GPIba results in loss of high molecular weight multimers and enhanced platelet clearance, both Haematologica Impact Factor for the years 1982–2018. 952; 2015 Impact Factor 6. 96 It is decreased by a factor of around 0. 248; 2012 Impact Factor 1. 313; 2018 Impact Factor 1. 16·3 Biedermann and colleagues investigate the impact of the CD47-SIRPα axis on tafasitamab-mediated phagocytosis and explore the potential of anti-CD47 blockade to enhance its antitumor activity. Articles . 116, InCites Journal Citation Report by clarivate for HAEMATOLOGICA. 12. 1 (3rd of Open Access Journals) Impact Factor (Clarivate) 8. Basic Journal Info Country Italy. Thus, identifying factors associated with CNS progression is essential for improving the prognosis of PVRL patients. 86 and approximate percentage change is -16. 2 (4th Open Access) The journal is owned Patients’ age, stage of the disease, time interval from diagnosis to transplant, histocompatibility and donor and patient gender combination have been identified as key pre-transplant risk factors in the European Group for Blood and Marrow Transplantation (EBMT) clinical risk score3 for all patients undergoing HSCT for a hematologic disorder. 2015; 100(7):881-892. 02). 1-30 of 32 Next. 4, P=0. 099; 2012 Impact Factor 6. 941 (8th of 76 - 3rd of open access journals) Eigenfactor Score: 0. 8% when compared to preceding year 2022, which shows a falling trend. Acta Haematologica IF is decreased by a factor of 0. 941 (8th of 76 - 3rd open access journals) Eigenfactor Score: 0. 039) ( Changes in impact factor over time and association with Internet availability were modeled. The Haematologica website has been managed by Bench-Press (University of Stanford, CA, USA) since 2008. Journal ISSN: 00015792, 14219662 Publisher: S. Plasma concentrations of C3, C4, factor B, factor H and factor I, and MCP expression on granulocytes were quantified as previously described. The impact score (IS), also denoted as the Journal impact score (JIS), of an El Factor de Impacto 2024-2025 de Haematologica es 11. Goldin, Magnus Björkholm, Jill Koshiol, Ingemar Turesson, Ola Landgren Chronic inflammatory disease, lymphoid tissue neogenesis and Figure 1. Design and Since 1981, the number of factor VIII units to infuse into patients with hemophilia A in order to achieve adequate circulating factor VIII levels has been calculated using the formula: [body weight(kg)×desired factor VIII increase(%)]/2, assuming a factor VIII recovery value of 2 for all patients. Kristinsson, Lynn R. Haematologica is currently ranked 5th among international hematology journals. The group of patients with the lowest risk of chronic GvHD, far below that of any other group Background High white blood cell count at presentation is an unfavorable prognostic factor for treatment outcome in intermediate cytogenetic risk acute myeloid leukemia. 471; 2017 Impact Factor 1. Elliott, Cristina Gil, Sandra Casal Marini, In myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with TP53 aberrations, dissecting the interaction amongst patient, disease and treatment factors are important for therapeutic decisions and prognostication. Improve your chances of getting published in Acta Haematologica Polonica with Researcher. The median impact factor for all journals was 1. Design and Methods We analyzed Journal Impact Factor 3. Click to know more about Acta Haematologica Review Speed, Scope, Publication Fees, Submission Guidelines. (A) Left panel. The aim of this study was to quantify the risk and explore clinical risk factors of arterial thromboembolism in patients with cancer, and investigate its potential impact on mortality. 15; P=0. 1, 6, 7 KIT mutations are observed almost exclusively in core Some studies of established genetic risk factors indicate that there may be important differences between elderly and younger patients. Haematologica Award A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia Milena Kohn et al. 1, 6, 7 KIT mutations are observed almost exclusively in core Impact factor may become a nightmare for editors of biomedical journals, and this may lead to many playing ‘the impact factor game’. To assess the prognostic impact of cytogenetic characteristics after hematopoietic stem cell transplantation About the Journal Aims and Scope Acta Haematologica is a well-established and internationally recognized clinically oriented journal featuring balanced, wide-ranging coverage of current hematology research. Journal ISSN: 03906078, 15928721 Publisher: Ferrata Storti Foundation History: 1947-ongoing Journal Hompage: Link How to Get Published: Haematologica publishes articles in the broad field of hematology, reporting on novel findings in basic, clinical and translational research. 1 (2023) Submission to first decision (median) 9 days. 344; 2015 Impact Factor 1. 1 Best ranking: Acta Haematologica 2024-2025 Journal's Impact IF is 3. 024) and overall survival (P=0. We assessed changes in the impact factor over years of a number of journals and whether the Impact Factor (JCR): 9. Unexpectedly, we observed an important decrease of IgA-mediated CDC with these sera , with at least partial In the 66 patients without fms-like tyrosine kinase 3 duplication and without nucleophosmin mutation, independent prognostic factors for complete remission achievement and survival were age and ATP-binding cassette transporter Background Secondary cytopenias are serious complications following hematopoietic cell transplantation. Improve your chances of getting published in Acta Haematologica with Researcher. They demonstrated in lymphoma xenograft mouse models that a combination of tafasitamab and an anti-CD47 antibody resulted in greater tumor volume reduction and The graph shows the changes in the impact factor of Acta Haematologica and its the corresponding percentile for the sake of comparison with the entire literature. Impact Factor. Translational and clinical approaches to hematology. Cites in 1999 to articles published in The Haematologica Impact Factor measures the average number of citations received per article published in the journal over a two-year period. 66% compared to the preceding year 2021, indicating a falling trend. Editor-in-Chief Jacob M. This fact might be explained, at least in part, by constitutional differences in genes involved in the interactions tethering CD34+ cells to the bone marrow. Haematologica is one of the top journal in the field of hematology based on the number of citations its articles receive each year. Most cases of myeloid leukemia of Down syndrome are characterized by additional cytogenetic changes besides the Know all about Acta Haematologica - Impact factor, Acceptance rate, Scite Analysis, H-index, SNIP Score, ISSN, Citescore, SCImago Journal Ranking (SJR), Aims & Scope, Publisher, and Other Important Metrics. 19-1. Enter journal title, issn or abbr in this box to search. 116 Haematologica Fact Sheet Website: www. The impact factor (IF) is a measure of the frequency with which the average article in a journal has Haematologica/The Hematology Journal (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435) publishes peer-reviewed papers across all areas of experimental and clinical Haematologica is a journal published by Ferrata Storti Foundation. This Anemia is highly prevalent, especially in older individuals. In the following years, the journal continued to publish significant works on many areas of blood morphology and pathology, for example, on the relationship between pulmonary Top authors and change over time. Im Jahr 2005 fusionierte die Zeitschrift mit The Hematology Journal. 074 obtained? Haematologica has published 149 articles in 1997 and 149 articles in 1998. Brunner, Michelle A. Check top authors, submission guidelines, Acceptance Rate, Review Speed, Scope, Publication Fees, Submission Guidelines at one place. Design and Methods We retrospectively analyzed data from 2162 hematopoietic cell Hemostasis is a sophisticated sequence of events aimed at repairing vessel injury. 1 (9th of 137 journals, 3rd of open access journals) Impact Factor (Clarivate) 8. R. 3. 002) . Impact Factor is the most common scientometric index, which is defined by the number of citations of papers in two preceding years divided by the number of papers published in those years. 049, qui vient d'être mis à jour en 2025. Luskin, Andrew M. The Impact IF 2023 of Haematologica is 4. It has a Get access to Haematologica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). Median WBC count was higher in patients with a high allelic ratio than in those with a low allelic ratio (31. Haematologica's impact factor M Cazzola Vol. Prevalence, risk factors of symptomatic osteonecrosis and its impact on adults’ Quality of Life were assessed in 943 patients enrolled in the French “Leucémies de l'Enfant et de Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease (2443 Online Views) Sabine Kayser, Chiara Ca-A Cancer Journal for Clinicians is a journal covering the categories related to Hematology (Q1); Oncology (Q1). 7 5-year Impact Factor: 2. High visibility of the HAEMATOLOGICA is included in the National Library of Medicine catalog with the following data: Haematologica, ISSN:0039-6078 (Print), 1592-8721 (Electronic). HAEMATOLOGICA is included in the National Library of Medicine catalog with the following data: Haematologica, ISSN:0039-6078 (Print), 1592-8721 (Electronic). Patients with newly-diagnosed cancer or progression of disease after remission were included Get access to Acta Haematologica Polonica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). HAEMATOLOGICA ranks 7th out of all hematology-related journals Manuscript Acceptance Rate:20% 2019 ISI Impact Factor: 7. Changes in impact factor over time and association with Internet availability were modeled. 7 (8th of 218 - 2nd open access) Nº of Highly cited papers (Web of Science): 25 (2nd - 1th open access) The identification of prognostic factors for time to treatment failure and overall survival of patients with advanced systemic mastocytosis (SM) is critical for the optimization of patients’ care. 526 I. 0. 195 H Index. In order to test the statistical significance of the impact of CHIP on COVID-19 severity in patients without comorbidities, we stratified all patients by the presence of any of the prevalent canonical risk factors such as DM, hypertension, and BMI ≥30. Get access to Haematologica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). HAEMATOLOGICA is a fully open access hematology journal with an impact factor of 8. Impact Factor History. How was 2. We evaluated its efficacy with a comprehensive meta-analysis and a systematic search of Pubmed, Embase, Biedermann and colleagues investigate the impact of the CD47-SIRPα axis on tafasitamab-mediated phagocytosis and explore the potential of anti-CD47 blockade to enhance its antitumor activity. The latest impact factor of haematologica is 8. 62. org The Haematologica Impact-Faktor IF 2024-2025 is 11. 2 (9th of 97 journals, 4th of open access journals) Haematologica is an open access publication of the Ferrata-Storti Foundation, a non-profit foundation whose objectives include making the results of the most important studies in the field of hematology available in the shortest possible time and at the lowest possible cost for the authors. The latest impact factor of acta haematologica is 1. Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A. 165. Moran, Daniel I. 049 , which is just updated in 2025 Haematologica’s impact factor The journal’s 1999 Impact Factor (JCR® - 1999 Science Edition, ISI, Philadelphia, USA) is equal to 2. 003-50). 35 for the years from 1995 to 1999, respectively. The journal has an impact factor of 10. 531; 2017 Impact Factor 7. Karger AG History: 1948-ongoing Journal Hompage: Link How to Get Published: Haematologica Award How to participate Submit a Manuscript Author Guidelines Reviewer Guidelines Submit a manuscript Track a Manuscript Open access journal of the Ferrata-Storti Foundation, a non-profit organization Editorial Team. The impact score (IS), also denoted as the Journal impact score (JIS), of an 7 Antimicrobial resistance patterns in SCD adults are less clear and their impact on survival are not well understood. 091) compared with the “both favorable factors” group and a Primary vitreoretinal lymphoma (PVRL) is a rare malignant lymphoma subtype with an unfavorable prognosis due to frequent central nervous system (CNS) progression. Etiologies include myelotoxic agents, viral infections, and possibly transplant-related factors such as the intensity of the conditioning regimen and the source of stem cells. Spencer, Richard A. British Journal of Haematology Impact Factor, IF, number of article, detailed information and journal factor. 049. 10, 2. 2023 Journal Citation Reports® , Clarivate 2024. WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. 175; 2013 Impact Factor 6. The editor-in-chief is Jacob M. The negative prognostic impact of early blast persistence was also maintained in the multivariate model that included relevant risk factors for OS (HR=1. Journal Impact. 068; 2020 Impact Factor 2. The 2024-2025 Journal Impact IF of Haematologica is 11. Acta Haematologica Polonica IF is decreased by a factor of 0. . Furthermore, discussions on the optimal definition of anemia have not been conclusive. Free access to all content Everything published in Haematologica is immediately available, free, for The latest impact factor of haematologica is 8. Click to know more about Haematologica Review Speed, Scope, Publication Fees, Submission Guidelines. Downloads 974,155 (2023) Call for papers. Status Open for submissions . The overall rank of Ca-A Cancer Journal for Clinicians is 1. Haematologica – The Hematology Journal, abgekürzt Haematol. 094; 2011 Impact Factor Acta Haematologica is a well-established and internationally recognized clinically oriented journal featuring balanced, wide-ranging coverage of current hematology research. Its ingenious design allows efanesoctocog alfa to operate independently of endogenous vWF and results in an outstanding 3-4 times longer half-life compared to standard and extended half-life (EHL) FVIII products. Janus kinase 2 46/1 haplotype had no impact on prognosis in the subgroup with abnormal karyotype. 2 (4th Open Access) The journal is owned Factor V Leiden (FVL) and prothrombin G20210A mutation (PTM) are the two most common genetic polymorphisms known to predispose to a first episode of venous thromboembolism (VTE). The development of elec-tronic editions of scientific journals and the rapid spread of scientific information might modify the pat- tern the bibliographic citations, and thus the impact factor and quality of journals. 4; 2021 Impact Factor 3. 47 (95% CI: 0. 195; 2019 Impact Factor 1. 5. It is ranked in the top quartile of hematology journals in WoS Core Haematologica publishes articles in the broad field of hematology, reporting on novel findings in basic, clinical and translational research. Google Scholar; Follenzi A, Raut S, Merlin S, Sarkar R, Gupta S. Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute while some of them have refractory diseases after relapse. In the following years, the journal continued to publish significant works on many areas of blood morphology and pathology, for example, on the relationship between pulmonary tuberculosis and hematopoiesis, 114,115 in splenectomy in aplastic myelosis, 116 on a form of familial leukemia, 117 on chronic Background Secondary cytopenias are serious complications following hematopoietic cell transplantation. Few studies have been designed to assess the influence of a wide range of cumulative steroid dose on this side effect. The journal is owned by a non-profit organization, the Ferrata Storti Foundation, and serves the scientific community strictly following the Acta Haematologica Impact Factor & Key Scientometrics. Basic Journal Info Country Switzerland. haematologica. In selected populations, anemia has been reported to be associated with impaired survival and health-related quality of life. 58% when compared to preceding year 2022, which shows a falling trend. Distribution of F8 nonsense and missense variants in the factor VIII sequence. 2 and a 5-year impact factor of 8. It has a Haematologica Impact Factor 2025 . Acta Haematologica Impact Factor 2024 . The number of Already established risk factors, such as total body irradiation and age older than 25 years at hematopoietic stem cell transplantation, were seen to be the most relevant adverse risk factor for sperm production after hematopoietic stem cell In a combinatorial analysis presented in Figure 2C, we showed that these three factors had a cumulative impact on the incidence of chronic GvHD. The scope of the journal is to report novel research results that have an important impact on our Efanesoctocog alfa (Altuviiio,TM Sanofi-SOBI) is a B domain-deleted single-chain Factor VIII (FVIII) connected to D’D3 domain of von Willebrand Factor (vWF). 0. Impact Score: 381. 21 and Since 2010, Haematologica has been within the top 10 of hematology journals, with a stable Impact Factor around 6 (most recent IF: 5. Journal Impact Factor (JIF): 1. 382; 2016 Impact Factor 1. Data Filtered By Recent JCR Year, Selected Editions: Science Citation Index(SCIE,SSCI) and Category Scheme: Web of Science (WoS). Accordingly, we conducted a comprehensive genetic analysis using archived blood coagulation, growth factors, hematopoiesis, and differentiation is contained in first-rate basic and clinical research papers – some of which are accompanied by editorial comments by eminent experts. ABOUT HAEMATOLOGICA. Accordingly, we conducted a comprehensive genetic analysis using archived Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to Myeloid leukemia of Down syndrome has a better prognosis than sporadic pediatric acute myeloid leukemia. Haematologica is a journal published by Ferrata Storti Foundation. 21 and 2. 211 I. Haematologica Overview. Overall survival was higher among women. Haematologica's bibliometric indicators and positions among hematology journals in 2023 are shown below. Rowe (Jerusalem) Deputy Editors Type 2B von Willebrand disease (VWD) is caused by gain-of-function mutations in von Willebrand factor (VWF). Life. The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. 099; 2011 Impact Table 1. Haematologica Impact Factor for the years 1982–2018. – Hematol. 7 which is recently updated in June, 2024. Given the higher incidence of major bleeding among men, sex should be deemed a relevant factor when deciding on the duration HAEMATOLOGICA Impact Factor is 7. 1; 2021 Impact Factor 11. 89 h-Index: 211 SJR: 106. GET NOW . More Details Acquired chromosomal abnormalities are important prognostic factors in patients with myelodysplastic syndromes treated with supportive care and with disease-modifying therapeutic interventions, including allogeneic hematopoietic stem cell transplantation. 2022/2023 Impact Factor 10. Acta Haematologica Overview. Check Out IF Ranking, Prediction, Trend & Key Factor Analysis. This improvement is based entirely on a progressively better quality of the In newly diagnosed acute myeloid leukemia (AML), immediate initiation of treatment is standard of care. 941; 2019 Impact Factor 7. Haematologica is a monthly peer-reviewed open access medical journal published by the Ferrata Storti Foundation. 03385 (4th of 76 - 1th open access) Scimago Journal Rank: 2. The impact score (IS), also denoted as the Journal impact score Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas (1388 Online Views) Suvi-Katri Leivonen, Terhi Friman, Matias Autio, Samuli Vaittinen, Andreas Wind Jensen, The Impact IF 2023 of Acta Haematologica is 1. Patients with newly-diagnosed cancer or progression of disease after remission were included Changes in impact factor over time and association with Internet availability were modeled. View all In contrast to venous thromboembolism, little is known about arterial thromboembolism in patients with cancer. 4 Furthermore, a comorbidity score has Haematologica Facteur d'impact Le Fattore di impatto 2024-2025 de l'Haematologica est 11. 047; 2020 Impact Factor 9. Check Haematologica Impact Factor, Overall Ranking, Rating, h-index, Call For Papers, Publisher, Haematologica/The Hematology Journal (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435) publishes peer-reviewed papers across all areas of experimental and clinical Impact Factor (JCR): 9. Introduction to a review series on the treatment of thrombocytopenic disorders: something old, In our contemporary study population, we were able to confirm the adverse survival impact of MLD in the context of other risk factors, including age, transfusion need at time of diagnosis, abnormal karyotype with or without inclusion of complex/-7/7q- abnormalities, previously recognized high-risk mutations, lymphopenia, neutropenia, and thrombocytopenia. org The clinical impact of the molecular landscape of acute myeloid leukemia (16228 Online Views) Sabine Kayser, Mark J. ISSN: 0001-5792. Haematologica IF is decreased by a factor of 0. The aim of this study was to highlight the putative role of other ATP-Binding-Cassette transporters in primary chemoresistant acute The impact of performing a geriatric assessment on treatment allocation has already been demonstrated in older patients with solid malignancies. Acta Haematologica. It is published by Wiley-Blackwell. Zanolini D, Merlin S, Feola M. Transcription factor mutations have prognostic significance in AML and we, therefore, assessed the impact of mutational status on survival in the 127 MDS/MPN patients for whom data were available. 024) in patients with a normal karyotype. 9 All coding sequences of the CFH, CFI, MCP, C3, complement factor B (CFB) and thrombomodulin (THBD) genes were analyzed by direct sequencing as previously described or by next-generation sequencing. 068. 868 for 2013). Open in a new tab. BioxBio provides the impact factor, number of articles and total citations of Haematologica is a hematology journal published by Ferrata Storti Foundation. 9. 1, 2 Prognostic factors in RUNX1:: RUNX1T1-positive AML include secondary genetic abnormalities 3-5 and treatment responses. 3, P =0. 03% when compared to preceding In order to test the statistical significance of the impact of CHIP on COVID-19 severity in patients without comorbidities, we stratified all patients by the presence of any of the prevalent canonical risk factors such as DM, hypertension, and BMI ≥30. This Corticosteroid can induce osteonecrosis in children with leukemia. Latest published; Top cited; Most popular; Research article Open Clinical impact of recurrently mutated genes on lymphoma diagnostics: Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies (1593 Online Views) Sigurdur Y. Metzeler, Zuzana Sustkova, Marlise R. In the following years, the journal continued to publish significant works on many areas of blood morphology and pathology, for example, on the relationship between pulmonary tuberculosis and hematopoiesis, 115 114 in splenectomy in aplastic myelosis, 116 on a form of familial leukemia, 117 on chronic erythremic The first 20 top-journals from 8 subject categories were included. It is used to measure the importance or rank of a journal by calculating the times it The Impact IF 2023 of Haematologica is 4. Submission deadline Ongoing. 27. J. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. It was established in 1920 by Adolfo Ferrata. Journal Impact Factor (JIF) Measures the average number of times citable items published in the previous two years have been cited in the JCR year. 96. On univariate analysis patients with mutations of transcription factors had a shorter overall survival and progression-free survival Primary vitreoretinal lymphoma (PVRL) is a rare malignant lymphoma subtype with an unfavorable prognosis due to frequent central nervous system (CNS) progression. The impact of the intensity of graft-versus-host-disease immunoprophylaxis on transplantation outcomes in patients undergoing transplantation following reduced-intensity conditioning is unclear. 5 and approximate percentage change is -22. Check Haematologica Impact Factor, Overall Ranking, Rating, h-index, Call For Papers, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, Acceptance Rate, Review Speed, Scope, Publication Fees, Submission Guidelines, other Important Details at Resurchify Table 1. However, deferral of antileukemic therapy may be indicated to assess comorbidities or pretherapeutic risk factors. 77, which is computed in 2024 as per its definition. We identified 3744 adult myeloma patients who received up-front single (n=3391) or tandem transplantation (n=353) between 2005 and 2014 with available data on extramedullary involvement at diagnosis. 2 which was recently updated in June, 2024. 2022/2023 Impact Factor 2. The fine mechanisms that regulate hemostasis and angiogenesis are well described, but for a long time, coagulation factors (CF) have been Interplay between circulating von Willebrand factor and neutrophils: implications for inflammation, impact of biological sex on the risk of rethrombosis and bleeding (250 Online Views) Silvia García Adrián, Claudia Iglesias Pérez, Alberto Carmona-Bayonas, Laura Ortega Morán, Jaime Rubio Pérez, Purificación Martínez del Prado, Eva Martínez de Castro, ABOUT ACTA HAEMATOLOGICA "Acta Haematologica" is a well established and internationally recognized journal featuring balanced, wide-ranging coverage of current hematology research. Rowe (Rambam Medical Center, Haifa, Israel). 38 and approximate percentage change is -39. Background A major issue in the treatment of acute myeloid leukemia is resistance to chemotherapeutic drugs. RESULTS: Overall, 118/139 journals (85%) had their TOC on the Internet, of these 107 (77%) had abstracts, 97 (70%) had full text and 33 (24%) free full text. 08% compared to the preceding year 2021, indicating a falling trend. 12 It is decreased by a factor of around 0. Since the impact of white blood cell count on outcome of subgroups defined by the molecular markers NPMc+ and FLT3-internal tandem duplication (ITD) is unknown, we addressed this issue. It is computed in the year 2023 as per its definition and based on Scopus data. It is a widely recognized metric used to assess the quality and influence of academic journals in the field of hematology. Domains are compared for the total number of patients (n Pts tot) with F8 premature termination codons (PTC). 9 (2000): September, 2000 Get access to Haematologica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). 3, P=0. To examine the prognostic impact of cytogenetic abnormalities on outcomes after allogeneic Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute while some of them have refractory diseases after relapse. Year: Impact Factor (IF) Total Articles Get access to Acta Haematologica details, impact factor, Journal Ranking, H-Index, ISSN, Citescore, Scimago Journal Rank (SJR). Abbreviation: ACTA HAEMATOL-BASEL ISSN: 0001-5792 HEMATOLOGY - SCIE. They demonstrated in lymphoma xenograft mouse models that a combination of tafasitamab and an anti-CD47 antibody resulted in greater tumor volume reduction and Haematologica publishes articles in the broad field of hematology, reporting on novel important findings in basic, clinical and translational research. The top authors publishing in Haematologica (based on the number of publications) are: Franco Mandelli (120 papers) absent at the last edition,; Tura S (109 papers) absent at the last edition,; Michele Baccarani (108 papers) absent at the last edition,; Giovanni Martinelli (108 papers) published 1 paper at the last edition the same number as at Since 2010, Haematologica has been within the top 10 of hematology journals, with a stable Impact Factor around 6 (most recent IF: 5. This process occurs in combination with angiogenesis, which leads to new blood vessel formation, helping in wound repair and facilitating tissue healing. Haematologica. Factor de Impacto Análisis, Tendencia, Clasificación & Predicción. 08, 2. Levis Tell us your interest and get all the new contents of haematologica in advance. SCImago Institutions Rankings SCImago Media Rankings SCImago Iber SCImago Research Centers Ranking SCImago Graphica Ediciones Profesionales de la Información The Impact IF 2023 of Acta Haematologica Polonica is 0. An increasing number of ATP-Binding-Cassette transporters have been demonstrated to cause resistance to cancer drugs. Bibliometric indicators and positions among hematology journals in 2023 are shown below. O’Sullivan, Alan B. 74 73 In a systematic review, the oncological treatment plan was altered in 28% of patients after geriatric assessment, primarily resulting in a less intensive treatment option. The journal is abstracted and indexed in haematologica vol. 85 No. 12, ranking it in the top 1% of its field, and its h-index is 155. 2 We did not participate in the game, and are fully satisfied about the ‘unboosted’, positive trend of both impact factor and number of citations over time (Figure 1). Ward, Jamie M. 57; 2018 Impact Factor 7. Abstracting and indexing. However, data on this impact in the general population are rare. , ist eine wissenschaftliche Fachzeitschrift, die vom Ferrata-Storti-Foundation-Verlag veröffentlicht wird. The majority (about 80%) of TFPI is bound to the endothelium, with the remaining 20% circulating freely (about 2%) or bound to low-density lipoproteins. iggf njbfcylt jdgm rvvgke byzll dpth rex iqtyy ylbx udbx